Successful antihypertensive treatment using sacubitril/valsartan alone in a patient with obstructive sleep apnoea syndrome

Successful antihypertensive treatment using sacubitril/valsartan alone in a patient with obstructive sleep apnoea syndrome

Obstructive sleep apnoea syndrome (O-SAS) induces excessive activity of the sympathetic nervous system, resulting in secondary hypertension. Although continuous positive airway pressure (CPAP) is the first-line therapy for O-SAS, poor adherence to CPAP induces uncontrollable resistant hypertension....

Full description

Bibliographic Details
Main Authors: Ryuta Sugihara, Yuusaku Sugihara, Itsuko Sugihara, Yasushi Sakata
Format: Article
Language:English
Published: Elsevier España 2023-10-01
Series:Medicina Clínica Práctica
Subjects:
síndrome de apnea obstructiva del sueño
hipertensión
sacubitril/valsartán
Online Access:http://www.sciencedirect.com/science/article/pii/S2603924923000319

Internet

http://www.sciencedirect.com/science/article/pii/S2603924923000319

Similar Items